Rhenman & Partners Asset Management Ab Zai Lab LTD Transaction History

Rhenman & Partners Asset Management Ab

  • $1.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$105.0 - $178.37 $3.68 Million - $6.24 Million
-35,000 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$125.11 - $180.0 $1.25 Million - $1.8 Million
-10,000 Reduced 22.22%
35,000 $6.2 Million
Q1 2021

May 14, 2021
BUY
$126.27 - $191.71 $5.68 Million - $8.63 Million
45,000 New
45,000 $6 Million

Others Institutions Holding ZLAB

# of Institutions
121
Shares Held
46.7M
Call Options Held
223K
Put Options Held
588K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.56B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email